Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Rheumatology

Your Child's Care Team and Ongoing Monitoring

At a Glance

Children with AIFEC need coordinated long-term care from pediatric rheumatology or immunology, gastroenterology, genetics, nutrition, and other specialists. Regular labs, growth and stool checks, infection planning, and symptom tracking help detect flares early.

Managing AIFEC is a marathon that requires a dedicated team of specialists sharing responsibility for your child’s care. Because the disease affects multiple systems—from the immune system to the digestive tract—no single doctor can manage it alone. You are an essential part of coordinating this care between various specialists to ensure your child receives cohesive treatment [1].

Your Multidisciplinary Care Team

A “medical home” for a child with AIFEC typically includes the following specialists who should communicate with each other regularly:

  • Pediatric Rheumatologist/Immunologist: These are usually the lead specialists. They manage the “stuck-on” immune response and prescribe targeted biologic medications [1][2].
  • Pediatric Gastroenterologist (GI): Since the gut is a primary target of AIFEC, the GI doctor monitors for intestinal ulcers and manages the severe enterocolitis [3].
  • Medical Geneticist: They help interpret the specific NLRC4 mutation and can provide guidance on whether other family members should be tested [2][4].
  • Pediatric Dietitian: A specialist dietitian is essential for tracking growth and creating a nutrition plan (such as elemental formulas or TPN) that compensates for poor absorption in the gut [3].
  • Pediatric Surgeon & Intensivist: While not involved daily, these specialists are critical for managing emergencies like bowel injury or life-threatening flares (MAS/Shock) [5][6].

Long-Term Monitoring and Surveillance

Consistent monitoring helps your team catch “silent” inflammation before it becomes a full-blown crisis. Frequency of testing depends on age, symptoms, and treatment toxicity, rather than a universal fixed schedule.

Routine Lab Work

Your child will likely need blood draws at intervals determined by their disease activity. Key markers include:

  • Complete Blood Count (CBC): To check for anemia and track white blood cell and platelet counts [7].
  • Inflammatory Markers (CRP and ESR): To measure the general level of “fire” in the body [3].
  • Ferritin: This is a critical marker for Macrophage Activation Syndrome (MAS). While there is no universal “safe zone,” a sudden, sharp rise in ferritin is a major warning sign [7][8].
  • Liver Enzymes and Coagulation: These tests help ensure that the liver and blood-clotting systems are functioning correctly during flares [7].
  • IL-18: While IL-18 is often high in AIFEC, tracking its trend can provide context for the overall disease state [9][10].

Growth and Gut Checks

Because inflammation can “steal” energy from growth, your team will closely monitor:

  • Growth Curves: Precise tracking of height, weight, and (in infants) head circumference [3].
  • Stool Testing: Checking for “calprotectin” (a marker of gut inflammation, which requires age-appropriate interpretation in infants) or hidden blood.
  • Endoscopy: Visual checks of the intestinal lining are performed when clinically justified by symptoms or to make major treatment decisions [3].

Day-to-Day Life and Infection Prevention

Living with a child on immune-suppressing drugs requires extra precautions.

  • Infection Awareness: Because medications like anakinra or infliximab dampen the immune system, your child may be at higher risk for infections [11]. It can be difficult to tell if a fever is a “flare” or a “germ”; always follow your specific written infection action plan if a fever occurs while your child is on these drugs [12].
  • Vaccination Planning: Health education is key to protecting your child. You should work with your immunologist to determine which vaccines are safe. Live-virus vaccines are often avoided depending on the specific drug and dose, but non-live vaccines are frequently recommended and vital for protection [13].
  • Symptom Tracking: Keeping a simple daily log of stool frequency, fever height, and energy levels can help you spot subtle patterns that a doctor might miss during a brief office visit [14].

Navigating the Psychological Toll

Caring for a child with an ultra-rare, unpredictable illness is an immense emotional burden. Test anxiety (stress before labs or scans) and the constant “waiting for the other shoe to drop” are common experiences for parents [15]. A genetics counselor can also help address recurrence-risk questions, parental mosaicism, and interpretation of uncertain variants.

Research shows that successful treatment—finding the right medication to control flares—can significantly improve the quality of life for the entire family [16][17]. Ask your social worker for practical support, such as travel/emergency letters, school accommodations, or connections to rare-disease registries and guidance for the eventual transition to adult care.

Common questions in this guide

Who usually leads my child's AIFEC care team?
A pediatric rheumatologist or immunologist often serves as the lead specialist for AIFEC. The team may also include a pediatric gastroenterologist, medical geneticist, dietitian, and pediatric surgery or intensive-care specialists for urgent problems.
Which blood tests are commonly used to monitor AIFEC?
Monitoring may include a complete blood count, CRP and ESR, ferritin, liver enzymes, blood-clotting tests, and IL-18. The care team chooses the timing based on your child's age, symptoms, disease activity, and medication risks; a sudden ferritin rise can signal a serious flare.
How will doctors monitor my child's gut and growth?
The team follows height, weight, and, for infants, head circumference, along with stool frequency and tests such as calprotectin or hidden blood. Endoscopy may be considered when symptoms or major treatment decisions make it clinically necessary.
What should I do if my child develops a fever while taking AIFEC medicines?
A fever can be caused by infection or an inflammatory flare, and immune-suppressing medicines can increase infection risk. Follow your child's written infection action plan and contact the care team or seek urgent care as that plan directs.
Are vaccines safe while my child is receiving immune-suppressing treatment?
Ask your child's immunologist to review every vaccine based on the medication and dose. Live-virus vaccines may be avoided in some situations, while non-live vaccines are often recommended to help protect against infection.
How can our family prepare for AIFEC flares and long-term care?
Keep a simple log of fevers, stool frequency, and energy, and maintain a written emergency plan and go-bag for nights or weekends. Social workers, mental-health professionals, genetic counselors, and rare-disease resources can help with emotional support, school needs, travel, and family planning.

Get notified when new evidence is published on Periodic fever-infantile enterocolitis-autoinflammatory syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Autoinflammatory Diseases: A Review.

    An J, Marwaha A, Laxer RM

    The Journal of rheumatology 2024; (51(9)):848-861 doi:10.3899/jrheum.2023-1209.

    PMID: 38879186
  2. 2

    NLRC4 inflammasomopathies.

    Romberg N, Vogel TP, Canna SW

    Current opinion in allergy and clinical immunology 2017; (17(6)):398-404 doi:10.1097/ACI.0000000000000396.

    PMID: 28957823
  3. 3

    Autoinflammation with infantile enterocolitis associated with a novel CARD domain mutation in NLRC4: a case report and literature review.

    Mao Y, Xie Y

    Frontiers in pediatrics 2026; (14()):1878056 doi:10.3389/fped.2026.1878056.

    PMID: 42534928
  4. 4

    Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18.

    Alehashemi S, Goldbach-Mansky R

    Frontiers in immunology 2020; (11()):1840 doi:10.3389/fimmu.2020.01840.

    PMID: 32983099
  5. 5

    Autoinflammation with infantile enterocolitis induced by a heterozygous variant (c.1357C > T) in the NLRC4 gene: a case report.

    Wang X, Xiao Y, Ge T, et al.

    Frontiers in pediatrics 2026; (14()):1822554 doi:10.3389/fped.2026.1822554.

    PMID: 42290740
  6. 6

    NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood.

    Bardet J, Laverdure N, Fusaro M, et al.

    Journal of clinical medicine 2021; (10(19)) doi:10.3390/jcm10194369.

    PMID: 34640385
  7. 7

    Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment.

    Lee J, Bae KS, Rhim JW, et al.

    Children (Basel, Switzerland) 2024; (11(7)) doi:10.3390/children11070755.

    PMID: 39062205
  8. 8

    Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

    Henderson LA, Cron RQ

    Paediatric drugs 2020; (22(1)):29-44 doi:10.1007/s40272-019-00367-1.

    PMID: 31732958
  9. 9

    Free IL-18 in NLRC4-associated autoinflammatory disease without macrophage activation syndrome.

    Willemsen M, Schoonbrood THM, Rodriguez E, et al.

    Rheumatology (Oxford, England) 2026; (65(7)) doi:10.1093/rheumatology/keag363.

    PMID: 42444142
  10. 10

    [Autoinflammatory diseases associated with IL-18].

    Mertz P, Hentgen V, Boursier G, et al.

    La Revue de medecine interne 2025; (46(3)):155-163 doi:10.1016/j.revmed.2024.08.003.

    PMID: 39155178
  11. 11

    Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

    De Benedetti F, Gattorno M, Anton J, et al.

    The New England journal of medicine 2018; (378(20)):1908-1919 doi:10.1056/NEJMoa1706314.

    PMID: 29768139
  12. 12

    The Silent Infection: Cytokine Blockade, Blunted Sepsis Physiology, and Soft Tissue Infection With NLRP12-Associated Autoinflammatory Syndrome.

    Izadian Bidgoli A, Gomez Veliz A

    Cureus 2026; (18(5)):e109484 doi:10.7759/cureus.109484.

    PMID: 42338869
  13. 13

    Influenza vaccine uptake in juvenile idiopathic arthritis during the COVID-19 pandemic: a multi-centre cross-sectional study by PRES vaccination working party.

    Maritsi D, Alpert N, Bizjak M, et al.

    Pediatric rheumatology online journal 2025; (23(1)):103 doi:10.1186/s12969-025-01158-4.

    PMID: 41094677
  14. 14

    Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC).

    Asna Ashari K, Parvaneh N, Mirnia K, et al.

    Pediatric rheumatology online journal 2024; (22(1)):90 doi:10.1186/s12969-024-01020-z.

    PMID: 39425177
  15. 15

    Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood.

    Welzel T, Benseler SM, Kuemmerle-Deschner JB

    Frontiers in immunology 2021; (12()):516427 doi:10.3389/fimmu.2021.516427.

    PMID: 33868220
  16. 16

    Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial.

    Lachmann HJ, Lauwerys B, Miettunen P, et al.

    Clinical and experimental rheumatology 2021; (39 Suppl 132(5)):51-58 doi:10.55563/clinexprheumatol/e92f7o.

    PMID: 34622762
  17. 17

    JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

    Sanchez GAM, Reinhardt A, Ramsey S, et al.

    The Journal of clinical investigation 2018; (128(7)):3041-3052.

    PMID: 29649002

This page is for informational purposes only and does not constitute medical advice about your child's AIFEC care. Your child's pediatric specialists should determine monitoring, medications, vaccinations, and emergency actions for your specific situation.